Baudax Bio (BXRX) News Today → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free BXRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative October 18, 2023 | finance.yahoo.comBaudax Bio Announces Corporate UpdateOctober 2, 2023 | msn.comBaudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug TagSeptember 28, 2023 | investorplace.comWhy Is Baudax Bio (BXRX) Stock Up 75% Today?September 28, 2023 | marketwatch.comBaudax Bio Shares Double After Orphan Drug Designation for TI-168September 28, 2023 | markets.businessinsider.comBaudax Bio: FDA Grants Orphan Drug Designation To TI-168 For Hemophilia A With InhibitorsSeptember 18, 2023 | finance.yahoo.comHere's Why Baudax Bio, Inc. (BXRX) Is a Great 'Buy the Bottom' Stock NowSeptember 7, 2023 | finance.yahoo.comBaudax Bio to Participate in the H.C. Wainwright Global Investment ConferenceAugust 23, 2023 | finance.yahoo.comBaudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common StockAugust 17, 2023 | finance.yahoo.comBaudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 16, 2023 | finance.yahoo.comBaudax Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateJune 30, 2023 | investorplace.comWhy Is Baudax Bio (BXRX) Stock Up 130% Today?June 30, 2023 | marketbeat.comTrading was temporarily halted for "BXRX" at 11:06 AM with a stated reason of "LULD pause."June 30, 2023 | marketbeat.comTrading was temporarily halted for "BXRX" at 10:06 AM with a stated reason of "LULD pause."June 30, 2023 | marketbeat.comTrading was temporarily halted for "BXRX" at 10:06 AM with a stated reason of "LULD pause."June 30, 2023 | marketbeat.comTrading was temporarily halted for "BXRX" at 10:06 AM with a stated reason of "LULD pause."June 30, 2023 | marketbeat.comTrading was temporarily halted for "BXRX" at 10:06 AM with a stated reason of "LULD pause."June 8, 2023 | markets.businessinsider.comBaudax Bio (BXRX) Gets a Hold from Noble FinancialMay 22, 2023 | markets.businessinsider.comNoble Financial Sticks to Their Hold Rating for Baudax Bio (BXRX)May 15, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Cocrystal Pharma (COCP) and Baudax Bio (BXRX)May 12, 2023 | finanznachrichten.deBaudax Bio, Inc.: Baudax Bio Reports First Quarter Financial Results and Provides Business UpdateMay 12, 2023 | baystreet.caBaudax Improves on Q1 ResultsMay 12, 2023 | msn.comRecap: Baudax Bio Q1 EarningsMay 12, 2023 | finance.yahoo.comBaudax Bio Reports First Quarter Financial Results and Provides Business UpdateMay 3, 2023 | finance.yahoo.comBaudax Bio to Present at the Sidoti Virtual Investor ConferenceMay 1, 2023 | finance.yahoo.comBaudax Bio Announces Closing of $4 Million Public OfferingApril 27, 2023 | msn.comWhy NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionApril 27, 2023 | investorplace.comWhy Is Baudax Bio (BXRX) Stock Down 52% Today?April 27, 2023 | finance.yahoo.comBaudax Bio Announces Pricing of $4 Million Public OfferingApril 25, 2023 | msn.comBaudax Bio Soars after Positive Topline DataApril 25, 2023 | msn.comBaudax Bio's Nerve Blockade Aces Mid-Stage Study In Surgery PatientsApril 24, 2023 | finance.yahoo.comBaudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 TrialFebruary 28, 2023 | msn.comLooking Into Baudax Bio's Return On Capital EmployedFebruary 23, 2023 | finance.yahoo.comBaudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business UpdateJanuary 25, 2023 | marketwatch.comBaudax Bio Shares Drop 17% After Tuesday Rise on BX-1000 Trial ResultsJanuary 25, 2023 | marketbeat.comIs the Pain Over for Baudax Bio Investors after a 70% Spike? Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.January 24, 2023 | benzinga.comWhy Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionJanuary 24, 2023 | investorplace.comWhy Is Baudax Bio (BXRX) Stock Up 50% Today?January 24, 2023 | marketbeat.comTrading was temporarily halted for "BXRX" at 09:01 AM with a stated reason of "LULD pause." Trading set to resume at 09:01 AM. January 24, 2023 | marketbeat.comTrading was temporarily halted for "BXRX" at 09:01 AM with a stated reason of "LULD pause."January 3, 2023 | marketbeat.comTrading was temporarily halted for "BXRX" at 01:01 PM with a stated reason of "LULD pause."December 9, 2022 | msn.comWhy Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving PremarketDecember 9, 2022 | bizjournals.comLab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapyDecember 9, 2022 | marketbeat.comTrading was temporarily halted for "BXRX" at 09:12 AM with a stated reason of "LULD pause."December 9, 2022 | marketbeat.comTrading was temporarily halted for "BXRX" at 09:12 AM with a stated reason of "LULD pause."December 1, 2022 | finanznachrichten.deBaudax Bio, Inc.: Baudax Bio Announces 1-for-40 Reverse Stock SplitNovember 8, 2022 | finance.yahoo.comBaudax Bio Reports Third Quarter 2022 Financial Results and Business HighlightsSeptember 19, 2022 | finance.yahoo.comBaudax Bio Announces Distribution of Series B Preferred Stock to Holders of its Common StockSeptember 14, 2022 | benzinga.comThinking about buying stock in Cisco Systems, Sonnet BioTherapeutics, Nikola Corp, Baudax Bio, or Amyris?September 8, 2022 | finance.yahoo.comBaudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare ConferenceAugust 30, 2022 | bizjournals.comBaudax Bio stock price plummets after firm announces $6.2M public offering Get Baudax Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. BXRX Media Mentions By Week BXRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BXRX News Sentiment▼0.000.42▲Average Medical News Sentiment BXRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BXRX Articles This Week▼00▲BXRX Articles Average Week Get Baudax Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SBFM News GRI News BDRX News PBLA News LSDI News EVLO News SPRC News EVFM News NBSE News BLPH News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BXRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baudax Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
